The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS), has granted a three-year renewed accreditation to the Prevea Cancer Center at HSHS Sacred Heart Hospital. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
Because it’s a CoC-accredited cancer center, the Prevea Cancer Center at HSHS Sacred Heart Hospital takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care.
“This level of accreditation reflects the dedication of our team of providers, nurses, therapists, and other professionals who make up our cancer program,” said Angela Quick, director of oncology, Prevea Cancer Center at HSHS Sacred Heart Hospital. “We’re honored to receive this renewed accreditation, which signifies the high level of care our patients receive.”
Applying for and maintaining CoC accreditation is a voluntary commitment by a cancer program that ensures its patients will have access to the full scope of services required to diagnose, treat, rehabilitate, and support patients with cancer.
“HSHS Sacred Heart Hospital has been accredited by the Commission on Cancer for the past 43 years,” said Andrew Bagnall, president and CEO, HSHS Sacred Heart Hospital. “This is attributed to the exceptional quality care we provide our patients.”
Prevea Health, a multi-specialty health care organization, began providing cancer care at HSHS Sacred Heart Hospital in 2016. The Prevea Cancer Center at HSHS Sacred Heart Hospital opened for patient care in September 2018.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care.